This treatment has been assessed in phase I and II clinical trials and showed benefit in advanced ovarian cancer [118], Ewing sarcoma [119] and hepatocellular carcinoma [120], indicating that furin repression has therapeutic potential in the treatment of some types of cancer. This evidence concerns the gene FURIN and cancer.